Replies to post #181986 on Biotech Values

[DewDiligence]

OrbiMed affiliate completes acquisition of RPBIF for $1.12/sh in cash (a 51% premium to the price on 6/15/16, the day before the acquisition announcement):

http://finance.yahoo.com/news/response-biomedical-corp-completes-going-174223449.html